Skip to main content

Therapeutics Startups

Updated November 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,733
Total Funding
$3.3B
Avg Funding
$132.6M
Global Reach
5
countries

Top Cities for Therapeutics

New York
Vancouver
San Francisco
Cambridge
Chicago
San Diego

Recently Funded Companies

Export
New York, United States

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

$805.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

BioNxt Solutions mission is to develop and commercialize next-generation pharmaceuticals.

$1.4M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.

$190.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.

$14.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Chicago, United States

Syntax Bio is a biotechnology company that develops a cell programming platform to control stem cell differentiation for research.

$14.4M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Replicate Bioscience develops self-replicating RNA therapeutics and vaccines delivering immunity at lower doses across multiple diseases.

$3.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Alameda, United States

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

$25.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Alameda, United States

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

$25.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Alameda, United States

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

$25.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Wilmington, United States

iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.

Jun 2026

Founder Contacts

41,000+ verified contacts

Skokie, United States

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

$50.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Watertown, United States

Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.

$65.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Piscataway, United States

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

$226.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Sera Medicines is an operator of biologics accelerator developing and launching next-generation protein therapeutics.

$38.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Altrincham, United Kingdom

FinalDose develops programmable DNA therapeutics that eliminate diseased cells by targeting pathogenic genetic sequences.

Jun 2026

Founder Contacts

41,000+ verified contacts

Sion, Switzerland

Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections through an AI-powered technology.

$1.1M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

München, Germany

HMNC Brain Health is a precision medicine pioneer in psychiatry based in Munich.

$50.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Woburn, United States

Zumutor Biologics develops immuno-oncology therapies that harness the body's innate immune system to treat cancer.

$7.3M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Boulder, United States

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

$460.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Thousand Oaks, United States

Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient.

$165.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

$600.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Tempe, United States

GT Medical Technologies develops medical technologies to improve outcomes for patients with brain tumors.

$100.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.

$99.5M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

$345.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Houston, United States

Goldenrod Therapeutics develops a small molecule to prevent pathogenic activity in immune cells.

$6.5M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Showing 151 to 175 of 1,733 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.

Average Funding
$132.6M
Total Funding Tracked
$3.3B
Countries Represented
5

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.Cambridge
3 companies$713.5M
2.Alameda
3 companies$75.0M
3.New York
1 companies$805.0M
4.Vancouver
1 companies$1.4M
5.San Francisco
1 companies$190.0M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked